Webinar Advancing Dyne 251 An Investigational Medicine For Duchenne To Deliver For Patients Parent Project Muscular Dystrophy Mp3 & Mp4 Download

53:00

webinar: dyne therapeutics — advancing dyne-251, an investigational medicine for dmd [jan 2024]

48:50

webinar: dyne therapeutics — advancing force in the pursuit of transformative therapies (april 2023)

42:18

webinar: viltepso - a treatment option for patients amenable to exon 53 skipping (april 2021)

37:27

webinar: viltepso, an fda-approved treatment for patients amenable to exon 53 skipping (march 2023)

1:06:22

webinar: srp-9001 data update from studies 101, 102, and 103 (august 2022)

53:56

[webinar] italfarmaco provides givinostat update - january 2018

58:48

webinar: transforming the treatment paradigm with dyne therapeutics (march 31, 2021)

58:18

[webinar] summit's utrophin modulation program - january 2017

1:08:13

[webinar] gene therapy for duchenne - august 2017

54:42

webinar: ataluren update with ptc

1:13:49

hope-duchenne trial - capricor therapeutics [january 2016 webinar]

1:09:52

webinar: srp-9001 micro-dystrophin gene therapy clinical update (october 2021)

33:36

community webinar: transforming the treatment paradigm for duchenne

1:09:05

[webinar] hope-2 duchenne clinical trial – capricor – july 2018

37:14

webinar: advancing dyne-251 - an investigational medicine for duchenne to deliver for patients

Download video MP4

Download video MP3

Similar videos

webinar: dyne therapeutics — advancing dyne-251, an investigational medicine for dmd [jan 2024]

webinar: dyne therapeutics — advancing force in the pursuit of transformative therapies (april 2023)

webinar: dyne therapeutics update on dyne-251 (july 2022)

community webinar: dyne-251 potentially transformative therapy for duchenne

[webinar] domagrozumab as a potential treatment for duchenne - may 2019

webinar: viltepso - a treatment option for patients amenable to exon 53 skipping (april 2021)

webinar: viltepso, an fda-approved treatment for patients amenable to exon 53 skipping (march 2023)

webinar: srp-9001 data update from studies 101, 102, and 103 (august 2022)

[webinar] italfarmaco provides givinostat update - january 2018

webinar: transforming the treatment paradigm with dyne therapeutics (march 31, 2021)

[webinar] summit's utrophin modulation program - january 2017

[webinar] gene therapy for duchenne - august 2017

webinar: ataluren update with ptc

hope-duchenne trial - capricor therapeutics [january 2016 webinar]

webinar: srp-9001 micro-dystrophin gene therapy clinical update (october 2021)

community webinar: transforming the treatment paradigm for duchenne

[webinar] hope-2 duchenne clinical trial – capricor – july 2018

cureduchenne and dyne therapeutics: dyne-251 transforming the treatment paradigm for dmd